TZJ-32159-16890
2 vaccinations
0 coded responses
1 check-in
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 992 / WA
- Registered
- 2021-06-07
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-06-07
Registered in v-safe
-
2021-06-07
Dose 1 — Janssen/Johnson & Johnson
-
2021-08-18
Dose 2 — Janssen/Johnson & JohnsonCo-administered: yes
-
2021-08-18
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitAdult check-in
-
2021-08-18
Report sent to call center — day 0, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-07 | Janssen/Johnson & Johnson | |
| 2 | 2021-08-18 | Janssen/Johnson & Johnson | Yes |
Call center
1 call center case
1 unsuccessful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.